Human skin penetration of selected model mycotoxins

Toxicology

Volumn 301, Issue 1-3, 2012, Pages 21-32

  Boonen, Jente ^a   Malysheva, Svetlana V ^a   Taevernier, Lien ^a   Diana Di Mavungu, José ^a   De Saeger, Sarah ^a   De Spiegeleer, Bart ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Dermal exposure; Human skin; Mycotoxins; Risk assessment; Transdermal penetration

Indexed keywords

AFLATOXIN B1; CITRININ; FUMONISIN B1; MYCOTOXIN; OCHRATOXIN; T 2 TOXIN; ZEARALENONE;

AGRICULTURAL WORKER; ARTICLE; CONCENTRATION (PARAMETERS); GRAIN DUST; HEALTH HAZARD; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIMIT OF DETECTION; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN PENETRATION; STEADY STATE;

ADULT; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MIDDLE AGED; MYCOTOXINS; PERMEABILITY; SKIN; SKIN ABSORPTION; TIME FACTORS;

EID: 84864819165     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.06.012     Document Type: Article

References (116)

1. Albarenque S.M., Doi K. T-2 toxin-induced apoptosis in rat keratinocyte primary cultures. Exp. Mol. Pathol. 2005, 78:144-149.
2. Albarenque S.M., Suzuki K., Shinozuka J., Nakayama H., Doi K. Kinetics of apoptosis-related genes mRNA expression in the dorsal skin of hypotrichotic WBN/ILA-Ht rats after topical application of T-2 toxin. Exp. Toxicol. Pathol. 2001, 52:553-556.
3. Albarenque S.M., Shinozuka J., Suzuki K., Nakayama H., Doi K. Kinetics and distribution of transforming growth factor (TGF)-beta 1 mRNA in the dorsal skin of hypotrichotic WBN/ILA-Ht rats following topical application of T-2 toxin. Exp. Toxicol. Pathol. 2000, 52:297-301.
4. Albarenque S.M., Shinozuka J., Iwamoto S., Nakayama H., Doi K. T-2 toxin-induced acute skin lesions in Wistar-derived hypotrichotic WBN/ILA-Ht rats. Histol. Histopathol. 1999, 14:337-342.
5. Antony M., Shukla Y., Janardhanan K.K. Protective effect of tenuazonic acid against dimethyl benz(a)antracene-induced skin carcinogenesis in mice. Teratog. Carcinog. Mutagen. 2002, 22:309-314.
6. Artusi M., Nicoli S., Colombo P., Bettini R., Sacchi A., Santi P. Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro. J. Pharm. Sci. 2004, 93:2431-2438.
7. Baert B., De Spiegeleer B. Local skin pharmacokinetics of talarozole, a new retinoic acid metabolism-blocking agent. Skin Pharmacol. Physiol. 2011, 24:151-159.
8. Baert B., Boonen J., Burvenich C., Roche N., Stillaert F., Blondeel P., Van Bocxlaer J., De Spiegeleer B. A new discriminative criterion for the development of franz diffusion tests for transdermal pharmaceuticals. J. Pharm. Pharm. Sci. 2010, 13:218-230.
9. Mycotoxins in Fruits and Vegetables 2008, Elsevier, Burlington. R. Barkai-Golan, N. Paster (Eds.).
10. Barlow S., Renwick A.G., Kleiner J., Bridges J.W., Busk L., Dybing E., Edler L., Eisenbrand G., Fink-Gremmels J., Knaap A., Kroes R., Liem D., Mueller D.J.G., Page S., Rolland V., Schlatter J., Tritscher A., Tueting W., Wurtzen G. Risk assessment of substances that are both genotoxic and carcinogenic - report of an International Conference organized by EFSA and WHO with support of ILSI Europe. Food Chem. Toxicol. 2006, 44:1636-1650.
11. Ben Salah-Abbes J., Abbes S., Abdel-Wahhab M.A., Oueslati R. In vitro free radical scavenging, antiproliferative and anti-zearalenone cytotoxic effects of 4-(methylthio)-3-butenyl isothiocyanate from Tunisian Raphanus sativus. J. Pharm. Pharmacol. 2010, 62:231-239.
12. Bhavanishankar T.N., Ramesh H.P., Shantha T. Dermal toxicity of Fusarium toxins in combinations. Arch. Toxicol. 1988, 61:241-244.
13. Benford D., Leblanc J.-C., Setzer R.W. Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic Example: Aflatoxin B1 (AFB1). Food Chem. Toxicol. 2010, 48:S34-S41.
14. Blaylock B.L., Kouchi Y., Comment C.E., Pollock P.L., Luster M.I. Topical application of T-2 toxin inhibits the contact hypersensitivity response in BALB/c mice. J. Immunol. 1993, 150:5135-5143.
15. Boonen J., Baert B., Lambert J., De Spiegeleer B. Skin penetration of silica microparticles. Pharmazie 2011, 66:463-464.
16. Boonen J., Baert B., Roche N., Burvenich C., De Spiegeleer B. Transdermal behaviour of the N-alkylamide spilanthol (affinin) from Spilanthes acmella (Compositae) extracts. J. Ethnopharmacol. 2010, 127:77-84.
17. Braese S., Encinas A., Keck J., Nising C.F. Chemistry and biology of mycotoxins and related fungal metabolites. Chem. Rev. 2009, 109:3903-3990.
18. Brown M.B., Martin G.P., Jones S.A., Akomeah F.K. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006, 13:175-187.
19. Bunner B.L., Wannemacher R.W., Dinterman R.E., Broski F.H. Cutaneous absorption and decontamination of [3H]T-2 toxin in the rat model. J. Toxicol. Environ. Health 1989, 26:413-423.
20. Bunner B.L., Wannemacher R.W., Dinterman R.E., Broski F.H. Dermal decontamination of [h-3] t-2 mycotoxin in rats. Toxicon 1988, 26:17.
21. CDER, 2005. Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers FDA, Rockville.
22. Cetin Y., Bullerman L.B. Cytotoxicity of Fusarium mycotoxins to mammalian cell cultures as determined by the MTT bioassay. Food Chem. Toxicol. 2005, 43:755-764.
23. Coulombe R.A. Biological actions of mycotoxins. J. Dairy Sci. 1993, 76:880-891.
24. Creppy E.E. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol. Lett. 2002, 127:19-28.
25. Crosera M., Bovenzi M., Maina G., Adami G., Zanette C., Florio C., Larese F.F. Nanoparticle dermal absorption and toxicity: a review of the literature. Int. Arch. Occup. Environ. Health 2009, 82:1043-1055.
26. Degen G.H. Tools for investigating workplace-related risks from mycotoxin exposure. World Mycotoxin J. 2011, 4:315-327.
27. Dehghanyar P., Mayer B.X., Namiranian K., Mascher H., Muller M., Brunner M. Topical skin penetration of diclofenac after single- and multiple-dose application. Int. J. Clin. Pharmacol. Ther. 2004, 42:353-359.
28. Dimitri R.A., Gabal M.A. Immunosuppressant activity of aflatoxin ingestion in rabbits measured by response to Mycobacterium bovis antigen 1. Cell mediated immune response measured by skin test reaction. Vet. Hum. Toxicol. 1996, 38:333-336.
29. Doi K., Ishigami N., Sehata S. T-2 toxin-induced toxicity in pregnant mice and rats. Int. J. Mol. Sci. 2008, 9:2146-2158.
30. Doorten A.Y.S., Bull S., Van der Doelen M.A.M., Fink-Gremmels J. Metabolism-mediated cytotoxicity of ochratoxin A. Toxicol. In Vitro 2004, 18:271-277.
31. EC, 2006. Commission Regulations (EC) Setting Maximum Levels for Certain Contaminants in Foodstuffs, p. 26.
32. ECETOC, 1993. Monograph Report No. 20 Percutaneous Absorption. European Centre for Ecotoxicology and Toxicology of Chemicals, Brussels.
33. Ehrlich V., Darroudi F., Uhl M., Steinkellner H., Zsivkovits M., Knasmueller S. Fumonisin B-1 is genotoxic in human derived hepatoma (HepG2) cells. Mutagenesis 2002, 17:257-260.
34. EMA ICH Topic Q3C (R5) Impurities: Guideline for Residual Solvents 2011, CHMP (Ed.), p. 26.
35. EPA Dermal Exposure Assessment: A Summary of EPA Approaches 2007, National Center for Environmental Assessment, Washington, DC.
36. EPA, 2012. Exposure Assessment. http://www.epa.gov/region8/r8risk/hh_exposure.html.
37. Flajs D., Mladinic M., Zeljezic D., Peraica M. Citrinin potentiates ochratoxin A toxicity. Toxicol. Lett. 2011, 205:S220-S221.
38. Flajs D., Peraica M. Toxicological properties of citrinin. Arh. Hig. Rada Toksikol. 2009, 60:457-464.
39. Flynn G.L. Mechanism of Percutaneous Absorption from Physicochemical Evidence 1985, Marcel Dekker, New York.
40. Grenier B., Oswald I.P. Mycotoxin co-contamination of food and feed: meta-analysis of publications describing toxicological interactions. World Mycotoxin J. 2011, 4:285-313.
41. Guerre P., Eeckhoutte C., Burgat V., Galtier P. The effects of T-2 toxin exposure on liver drug metabolizing enzymes in rabbit. Food Addit. Contam. 2000, 17:1019-1026.
42. Haighton L.A., Lynch B.S., Magnuson B.A., Nestmann E.R. A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model. Crit. Rev. Toxicol. 2012, 42:147-168.
43. Halstensen A.S. Species-specific fungal DNA in airborne dust as surrogate for occupational mycotoxin exposure?. Int. J. Mol. Sci. 2008, 9:2543-2558.
44. Halstensen A.S., Nordby K.C., Elen O., Eduard W. Ochratoxin A in grain dust - estimated exposure and relations to agricultural practices in grain production. Ann. Agric. Environ. Med. 2004, 11:245-254.
45. Hardin B.D., Robbins C.A., Fallah P., Kelman B.J. The concentration of no toxicologic concern (CoNTC) and airborne mycotoxins. J. Toxicol. Environ. Health Part A 2009, 72:585-598.
46. Hirokazu Fukuda H., Shima H., Vesonder R.F., Tokuda H., Nishino H., Katoh S., Tamura S., Sugimura T., Nagao M. Inhibition of protein serine/threonine phosphatases by fumonisin B1, a mycotoxin. Biochem. Biophys. Res. Commun. 1996, 220:160-165.
47. Hsia C.C., Wu Z.Y., Li Y.S., Zhang F., Sun Z.T. Nivalenol, a main Fusarium toxin in dietary foods from high-risk areas of cancer of esophagus and gastric cardia in China, induced benign and malignant tumors in mice. Oncol. Rep. 2004, 12:449-456.
48. Hussein H.S., Brasel J.M. Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology 2001, 167:101-134.
49. IRIS, 1993. Reference Dose (RfD): Description and Use in Health Risk Assessment.
50. JECFA, 1991. Evaluation of Certain Food Additives and Contaminants. Geneva, pp. 28-31.
51. Joffe A.Z., Ungar H. Cutaneous lesions produced by topical application of aflatoxin to rabbit skin. J. Invest. Dermatol. 1969, 52:504-507.
52. Juhasz J., Nagy P., Reiczigel J., Kulcsar M., Szigeti G., Huszenicza G. Effect of certain mycotoxins contaminating feedstuff (zearalenone, T-2 toxin) and dexamethasone on the reproductive function of horses. Summary report of a research program. Magy. Allatorvosok Lapja 2001, 123:475-482.
53. Kemppainen B.W. Skin absorption as a route of exposure for aflatoxin and trichothecenes. J. Toxicol. Toxin Rev. 1988, 7:95-120.
54. Kemppainen B.W., Riley R.T., Bilesthurlow S. Comparison of penetration and metabolism of [h-3] diacetoxyscirpenol, [h-3] verrucarin a and [h-3] t-2 toxin in skin. Food Chem. Toxicol. 1987, 25:379-386.
55. Kemppainen B.W., Riley R.T., Joyave J., Hoerr F.J. In vitro percutaneous penetration and metabolism of [3H]T-2 toxin: comparison of human, rabbit, guinea pig, and rat. Toxicon 1987, 25:185-194.
56. Kemppainen B.W., Riley R.T., Pace J.G., Hoerr F.J. Effects of skin storage conditions and concentration of applied dose on [3H] t-2 toxin penetration through excised human and monkey skin. Fundam. Appl. Toxicol. 1986, 24:221-227.
57. Knasmuller S., Cavin C., Chakraborty A., Darroudi F., Majer B.J., Huber W.W., Ehrlich V.A. Structurally related mycotoxins ochratoxin A, ochratoxin B, and citrinin differ in their genotoxic activities and in their mode, of action in human-derived liver (HepG2) cells: Implications for risk assessment. Nutr. Cancer - Int. J. 2004, 50:190-197.
58. Konoshima T., Takasaki M., Tokuda H. Anti-carcinogenic activity of the roots of Panax notoginseng. II. Biol. Pharm. Bull. 1999, 22:1150-1152.
59. Kruse J., Golden D., Wilkinson S., Williams F., Kezic S., Corish J. Analysis, interpretation, and extrapolation of dermal permeation data using diffusion-based mathematical models. J. Pharm. Sci. 2007, 96:682-703.
60. Kumar R., Dwivedi P.D., Dhawan A., Das M., Ansari K.M. Citrinin-generated reactive oxygen species cause cell cycle arrest leading to apoptosis via the intrinsic mitochondrial pathway in mouse skin. Toxicol. Sci. 2011, 122:557-566.
61. Kuiper-Goodman T., Hilts C., Billiard S.M., Kiparissis Y., Richard I.D.K., Hayward S. Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit. Contam. Part A - Chem. Anal. Control Expo. Risk Assess. 2010, 27:212-240.
62. Kuiper-Goodman T. Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone. Can. J. Physiol. Pharmacol. 1990, 68:1017-1024.
63. Lambert L.A., Hines F.A., Eppley R.M. Lack of initiation and promotion potential of deoxynivalenol for skin tumorigenesis in Sencar mice. Food Chem. Toxicol. 1995, 33:217-222.
64. Leese K.E., Cole E.C., Hall R.M., Berry M.A. Measurement of airborne and floor dusts in a nonproblem building. Am. Ind. Hyg. Assoc. J. 1997, 58:432-438.
65. Lindenfelser L.A., Lillehoj E.B., Burmeist H.R. Aflatoxin and trichothecene toxins - skin tumor induction and synergistic acute toxicity in white mice. J. Natl. Cancer Inst. 1974, 52:113-116.
66. Liu D.K., Wannemacher R.W., Snider T.H., Hayes T.L. Efficacy of the topical skin protectant in advanced development. J. Appl. Toxicol. 1999, 19:S41-S45.
67. Marasas W.F.O., Bamburg J.R., Smalley E.B., Strong F.M., Ragland W.L., Degurse P.E. Toxic effects on trouts, rats, and mice of T-2 toxin produced by fungus Fusarium tricinctum (Cd) Snyd et Hans. Toxicol. Appl. Pharmacol. 1969, 15:471-482.
68. Martins M.L., Martins H.M., Bernardo F. Fumonisins B1 and B2 in black tea and medicinal plants. J. Food Prot. 2001, 64:1268-1270.
69. Mayer S., Engelhart S., Kolk A., Blome H. The significance of mycotoxins in the framework of assessing workplace-related hazards. Gefahrstoffe Reinhalt. Luft 2007, 67:407-417.
70. Melchior W.B.J., Morris S.M., McGarrity L.J., Domon O.E., Muskhelishvili L., James S.J., Lindenfelser L.A., Lillehoj E.B., Burmeist H.R. Aflatoxin and trichothecene toxins - skin tumor induction and synergistic acute toxicity in white mice. J. Natl. Cancer Inst. 1974, 52:113-116.
71. Muro-Cacho C.A., Banasik M., Suchecki T.T., Persad A.S. Mycotoxins: mechanisms of toxicity and methods of detection for identifying exposed individuals. J. Land Use 2004, 19:537-556.
72. Nielsen K.F., Smedsgaard J. Fungal metabolite screening: database of 474 mycotoxins and fungal metabolites for dereplication by standardised liquid chromatography-UV-mass spectrometry methodology. J. Chromatogr. A 2003, 1002:111-136.
73. Njumbe Ediage E., Diana Di Mavungu J., Song S., Wu A., Van Peteghem C., De Saeger S. A direct assessment of mycotoxin biomarkers in human urine samples by LC-MS/MS. Anal. Chim. Acta 2012, 10.1016/j.aca.2012.06.038.
74. Nordby K.C., Halstensen A.S., Elen O., Clasen P.E., Langseth W., Kristensen P., Eduard W. Trichothecene mycotoxins and their determinants in settled dust related to grain production. Ann. Agric. Environ. Med. 2004, 11:75-83.
75. OECD, 2004. Guidance Document for the Conduct of Skin Absorption Studies. Publication: E.H.a.S. (Ed.), Paris.
76. Pang V.F., Swanson S.P., Beasley V.R., Buck W.B., Haschek W.M. The toxicity of T-2 toxin in swine following topical application. 1. Clinical signs, pathology, and residue concentrations. Fundam. Appl. Toxicol. 1987, 9:41-49.
77. Peraica M., Radic B., Lucic A., Pavlovic M. Toxic effects of mycotoxins in humans. Bull. World Health Organ. 1999, 77:754-766.
78. Pfohl-Leszkowicz A., Manderville R.A. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51:61-99.
79. Polizzi V., Delmulle B., Adams A., Moretti A., Susca A., Picco A.M., Rosseel Y., Kindt R.T., Van Bocxlaer J., De Kimpe N., Van Peteghem C., De Saeger S. JEM spotlight: fungi, mycotoxins and microbial volatile organic compounds in mouldy interiors from water-damaged buildings. J. Environ. Monit. 2009, 11:1849-1858.
80. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 1992, 9:663-669.
81. Rastogi S., Dogra R.K.S., Khanna S.K., Das M. Skin tumorigenic potential of aflatoxin B1 in mice. Food Chem. Toxicol. 2006, 44:670-677.
82. Rea W.J., Didriksen N., Simon T.R., Pan Y.Q., Fenyves E.J., Griffiths B. Effects of toxic exposure to molds and mycotoxins in building-related illnesses. Arch. Environ. Health 2003, 58:399-405.
83. Reboux G. Mycotoxins: health effects and relationship to other organic compounds. Rev. Fr. D Allergol. D Immunol. Clin. 2006, 46:208-212.
84. Reddy K.R.N., Salleh B., Saad B., Abbas H.K., Abel C.A., Shier W.T. An overview of mycotoxin contamination in foods and its implications for human health. Toxin Rev. 2010, 29:3-26.
85. Riviere J.E., Brooks J.D. Predicting skin permeability from complex chemical mixtures. Toxicol. Appl. Pharmacol. 2005, 208:99-110.
86. Riley R.T., Kemppainen B.W., Norred W.P. Penetration of aflatoxins through isolated human epidermis. J. Toxicol. Environ. Health 1985, 15:769-777.
87. Dermal Absorption and Toxicity Assessment 2007, INFRMA-HC, New York. M.S. Roberts, K.A. Walters (Eds.).
88. Santos L., Marin S., Sanchis V., Ramos A.J. Screening of mycotoxin multicontamination in medicinal and aromatic herbs sampled in Spain. J. Sci. Food Agric. 2009, 89:1802-1807.
89. Saxena N., Ansari K.M., Kumar R., Dhawan A., Dwivedi P.D., Das M. Patulin causes DNA damage leading to cell cycle arrest and apoptosis through modulation of Bax, p(53) and p(21/WAF1) proteins in skin of mice. Toxicol. Appl. Pharmacol. 2009, 234:192-201.
90. SCF, 2001. Opinion of the Scientific Committee on Food on Fusarium toxins Part 5: T-2 Toxin and HT-2 Toxin.
91. SCF, 2000. Opinion of the Scientific Committee on Food on Fusarium toxins Part 3: Fumonisin B1 (FB1).
92. SCF, 2000. Opinion of the Scientific Committee on Food on Fusarium toxins Part 2: Zearalenone (ZEA).
93. Scheie E., Smith B.L., Cox N., Flaoyen A. Spectrofluorometric analysis of phylloerythrin (phytoporphyrin) in plasma and tissues from sheep suffering from facial eczema. N. Z. Vet. J. 2003, 51:104-110.
94. SCHER/SCCP/SCENIHR, 2009. Scientific Opinion on the Risk Assessment Methodologies and Approaches for Genotoxic and Carcinogenic Substances.
95. Selim M.I., Juchems A.M., Popendorf W. Assessing airborne aflatoxin B1 during on-farm grain handling activities. Am. Ind. Hyg. Assoc. J. 1998, 59:252-256.
96. Shinohara Y., Arai M., Hirao K., Sugihara S., Nakanishi K., Tsunoda H., Ito N. Combination effect of citrinin and other chemicals on rat-kidney tumorigenesis. Gann 1976, 67:147-155.
97. Smoragiewicz W., Cossette B., Boutard A., Krzystyniak K. Trichothecene mycotoxins in the dust of ventilation systems in office buildings. Int. Arch. Occup. Environ. Health 1993, 65:113-117.
98. Solberg V.B., Broski F.H., Dinterman R.E., George D.T. Penentration of [H-3] T-2 mycotoxin through abraded and intact skin and methods to decontaminate [H-3] T-2 mycotoxin from abrasions. Toxicon 1990, 28:803-811.
99. Soroka P.M., Cyprowski M., Szadkowska-Stanczyk I. Occupational exposure to mycotoxins in various branches of industry. Med. Pr. 2008, 59:333-345.
100. Tangni E.K., Pussemier L. Ergosterol and mycotoxins in grain dusts from fourteen Belgian cereal storages: a preliminary screening survey. J. Sci. Food Agric. 2007, 87:1263-1270.
101. Terr A.I. Sick Building Syndrome: is mould the cause?. Med. Mycol. 2009, 47:S217-S222.
102. Tolleson W.H., Melcior W.B., Morris S.M., McGarrity L.J., Domon O.E., Muskhelishvili L., James S.J., Howard P.C. Apoptotic and anti-proliferative effects of fumonisin B-1 in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells. Carcinogenesis 1996, 17:239-249.
103. USEPA, 1997. Exposure Factors Handbook. Washington, DC.
104. van der Merwe D., Riviere J.E. Effect of vehicles and sodium lauryl sulphate on xenobiotic permeability and stratum corneum partitioning in porcine skin. Toxicology 2005, 206:325-335.
105. Vanyi A., Glavits R., Molnar T. Reproductive disorders due to F-2 and T-2 toxins in large-scale pig farms. Magy. Allatorvosok Lapja 1995, 50:424-430.
106. Varga J., Toth B. Novel strategies to control mycotoxins in feeds: a review. Acta Vet. Hung. 2005, 53:189-203.
107. Wei R.D., Smalley E.B., Strong F.M. Improved skin test for detection of T-2 toxin. Appl. Microbiol. 1972, 23:1029-1030.
108. Wester R.C., Melendres J., Sedik L., Maibach H.I. Percutaneous-absorption of azone following single and multiple doses to human volunteers. J. Pharm. Sci. 1994, 83:124-125.
109. WHO, 2006. Environ. Health Criteria 235: Dermal absorption. Geneva, p. 197.
110. Williams A.C., Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 2004, 56:603-618.
111. Wilschut A., Ten Berge W., Robinson P.J., McKone T.E. The validation of five mathematical skin permeation models. Chemosphere 1995, 30:1275-1295.
112. Wogan G.N., Paglialu S., Newberne P.M. Carcinogenic effects of low dietary levels of aflatoxin-b1 in rats. Food Cosmet. Toxicol. 1974, 12:681-685.
113. Wu Q., Dohnal V., Huang L., Kuca K., Yuan Z. Metabolic pathways of trichothecenes. Drug Metab. Rev. 2010, 42:250-267.
114. Yang S., Xia Q.J. Studies on the promoting and initiating effects of Fusarium T-2 toxin. Chinese J. Oncol. 1988, 17:107-110.
115. Yoshizawa T., Sakamoto T., Okamoto K. In vitro formation of 3'-hydroxy t-2 and 3'-hydroxy ht-2 toxins from t-2 toxin by liver homogenates from mice and monkeys. Appl. Environ. Microbiol. 1984, 47:130-134.
116. Zain M.E. Impact of mycotoxins on humans and animals. J. Saudi Chem. Soc. 2011, 15:129-144.